financetom
Business
financetom
/
Business
/
Impinj Insider Sold Shares Worth $3,073,471, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Impinj Insider Sold Shares Worth $3,073,471, According to a Recent SEC Filing
Oct 31, 2024 11:31 AM

03:29 AM EDT, 10/31/2024 (MT Newswires) -- Cary Baker, Chief Financial Officer, on October 28, 2024, sold 15,000 shares in Impinj ( PI ) for $3,073,471. Following the Form 4 filing with the SEC, Baker has control over a total of 71,096 shares of the company, with 71,096 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1114995/000141588924025782/xslF345X05/form4-10302024_101042.xml

Price: 198.78, Change: +7.06, Percent Change: +3.68

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Surgical robotics firm Procept Biorobotics Q3 revenue beats expectations on higher US system sales
Surgical robotics firm Procept Biorobotics Q3 revenue beats expectations on higher US system sales
Nov 4, 2025
Overview * Procept Biorobotics ( PRCT ) Q3 revenue grows 43% yr/yr, beating analyst expectations * Adjusted EBITDA for Q3 beats consensus, showing improved operational performance * Company maintains fiscal yr 2025 revenue guidance, issues optimistic 2026 forecast Outlook * Company maintains 2025 revenue guidance at $325.5 mln, up 45% from 2024 * Company projects 2026 revenue between $410 mln...
Restaurant technology platform Toast Q3 revenue beats estimates on new product launches
Restaurant technology platform Toast Q3 revenue beats estimates on new product launches
Nov 4, 2025
Overview * Toast Q3 2025 revenue beats analyst expectations, net income rises yr/yr * Company added 7,500 net new locations, boosting ARR by 30% to $2 bln * Toast expands AI capabilities and strategic partnerships, indicating confidence in growth Outlook * Toast expects Q4 non-GAAP gross profit of $480 mln to $490 mln, up 22-25% * Company projects Q4 adjusted...
Irish biopharma firm Avadel's Q3 revenue up 55%, but net income misses estimates
Irish biopharma firm Avadel's Q3 revenue up 55%, but net income misses estimates
Nov 4, 2025
Overview * Avadel Q3 net product revenue rises 55% yr/yr to $77.5 mln * However, net income for missed analysts' expectations as costs rose sharply Outlook * Company expects Alkermes acquisition to close in Q1 2026 * Avadel progressing REVITALYZ trial for LUMRYZ, completion expected by end of 2025 * Settlement with Jazz allows LUMRYZ commercialization beyond narcolepsy from March...
Lumentum Fiscal Q1 Adjusted Earnings, Revenue Rise; Issues Q2 Outlook
Lumentum Fiscal Q1 Adjusted Earnings, Revenue Rise; Issues Q2 Outlook
Nov 4, 2025
04:38 PM EST, 11/04/2025 (MT Newswires) -- Lumentum ( LITE ) reported fiscal Q1 adjusted earnings Tuesday of $1.10 per diluted share, compared with $0.18 a year earlier. Analysts polled by FactSet expected $1.03. Net revenue for the quarter ended Sept. 27 was $533.8 million, up from $336.9 million a year earlier. Analysts surveyed by FactSet expected $526.5 million. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved